Profil bibliographique

Lindsay Angus

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

81Publications signalées

1742Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Radiomics and Machine Learning in Medical ImagingCancer Genomics and DiagnosticsRenal cell carcinoma treatmentBrain Metastases and TreatmentMedical Imaging Techniques and Applications

Publications récentes

Accès ouvert 2026 articleOpenAlex

Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer

Bertha Eisses, Lindsay Angus, Evelien Kuip, C Willemien Menke-van der Houven van Oordt et autres

0 citationsDiagnostics

Accès ouvert 2026 articleOpenAlex

18 F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer

Jasper JL van Geel, Bertha Eisses, Sjoerd G. Elias, Adrienne H. Brouwers et autres

0 citationsJAMA Oncology

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Data S1 from Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer

Sophie L. Gerritse, Erik J. van Helden, Anne I.J. Arens, Ronald Boellaard et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S1 from Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer

Sophie L. Gerritse, Erik J. van Helden, Anne I.J. Arens, Ronald Boellaard et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Data from Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer

Sophie L. Gerritse, Erik J. van Helden, Anne I.J. Arens, Ronald Boellaard et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S1 from Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer

Sophie L. Gerritse, Erik J. van Helden, Anne I.J. Arens, Ronald Boellaard et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S2 from Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer

Sophie L. Gerritse, Erik J. van Helden, Anne I.J. Arens, Ronald Boellaard et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S2 from [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma

Sarah R. Verhoeff, Sjoukje F. Oosting, Sjoerd G. Elias, Suzanne C. van Es et autres

0 citations

Accès ouvert 2025 otherOpenAlex

Supplement LASSO from [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma

Sarah R. Verhoeff, Sjoukje F. Oosting, Sjoerd G. Elias, Suzanne C. van Es et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S1 from [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma

Sarah R. Verhoeff, Sjoukje F. Oosting, Sjoerd G. Elias, Suzanne C. van Es et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S3 from [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma

Sarah R. Verhoeff, Sjoukje F. Oosting, Sjoerd G. Elias, Suzanne C. van Es et autres

0 citations

Accès ouvert 2025 articleOpenAlex

Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer

Sophie L. Gerritse, Erik J. van Helden, Anne I.J. Arens, Ronald Boellaard et autres

0 citationsClinical Cancer Research

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.